ONMD

Yu Jeffrey

Known title: Chief Medical OfficerCIK: 0001991132

Yu Jeffrey's purchase track record

How the stock did after each of Yu Jeffrey's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
23
of 25 since December 8, 2023
Stock higher 6 months later
52%
3 months: 58%
Median 6-month return
+5.8%
3 months: +35.1%
Beat the S&P 500
43%
median -8.8% vs. index
PurchaseStockAmount3 months6 months
9/10/2026ONMD$90Kpendingpending
6/16/2026ONMD$200K+32.0%pending
4/1/2026ONMD$750K-13.6%+585.4%
9/18/2025ONMD$26K+38.2%-10.7%
9/4/2025ONMD$12K+113.9%-24.5%
8/27/2025ONMD$67K+74.0%-20.6%
8/19/2025ONMD$154K+66.9%-19.3%
6/20/2025ONMD$700K+162.7%+264.9%
12/18/2024ONMD$99-38.8%-62.8%
9/18/2024ONMD$2K+49.6%-8.4%
8/21/2024ONMD$122-21.5%-11.4%
8/12/2024ONMD$4K-30.0%-13.0%
5/10/2024ONMD$626+107.8%+39.2%
5/2/2024ONMD$556+129.6%+46.1%
4/24/2024ONMD$65+42.8%+20.9%
3/22/2024ONMD$79+53.2%-15.3%
3/6/2024ONMD$13+101.8%+17.6%
2/16/2024ONMD$82-51.0%+37.9%
2/8/2024ONMD$2-52.2%-12.0%
1/30/2024ONMD$2K-61.3%-2.7%
1/22/2024ONMD$9K+38.6%+100.2%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

ONMD Announces Multiyear Data Deal and 1-for-10 Reverse Split. OneMedNet signed a seven‑figure, multiyear agreement to supply derivative data to a partner. The company also announced a 1‑for‑10 reverse stock split effective September 29, 2026. With the share price near the top of its 52‑week range and an RSI above 96, the news highlights both a new revenue stream and a corporate action that may affect liquidity.

this person other insiders at ONMD

Transaction History

ONMD▲ Buy$90K
ONMD▲ Buy$100K
ONMD▲ Buy$100K
ONMD▲ Buy$750K
ONMD▲ Buy$182K
ONMD▲ Buy$0
ONMD▲ Buy$0
ONMD▲ Buy$1K
ONMD▲ Buy$18K
ONMD▲ Buy$5K
ONMD▲ Buy$380
ONMD▲ Buy$1K
ONMD▲ Buy$637
ONMD▲ Buy$2K
ONMD▲ Buy$10K
ONMD▲ Buy$9K
ONMD▲ Buy$21K
ONMD▲ Buy$9K
ONMD▲ Buy$14K
ONMD▲ Buy$15K
ONMD▲ Buy$120K
ONMD▲ Buy$10K
ONMD▲ Buy$12K
ONMD▲ Buy$13K
ONMD▲ Buy$700K
ONMD▼ Sell$1.3M
ONMD▼ Sell$546K
ONMD▲ Buy$99
ONMD▲ Buy$132K
ONMD▲ Buy$1K
ONMD▲ Buy$544
ONMD▲ Buy$122
ONMD▲ Buy$20
ONMD▲ Buy$13
ONMD▲ Buy$18
ONMD▲ Buy$3K
ONMD▲ Buy$1K
ONMD▲ Buy$626
ONMD▲ Buy$72
ONMD▲ Buy$72
ONMD▲ Buy$139
ONMD▲ Buy$210
ONMD▲ Buy$62
ONMD▲ Buy$65
ONMD▲ Buy$79
ONMD▲ Buy$13
ONMD▲ Buy$82
ONMD▲ Buy$2
ONMD▲ Buy$2K
ONMD▲ Buy$456
ONMD▲ Buy$988
ONMD▲ Buy$3K
ONMD▲ Buy$1K
ONMD▲ Buy$407
ONMD▲ Buy$374
ONMD▲ Buy$2K
ONMD▲ Buy$29
ONMD▲ Buy$0
ONMD▲ Buy$221
ONMD▲ Buy$11
ONMD▲ Buy$16
ONMD▲ Buy$17
ONMD▲ Buy$86
ONMD▲ Buy$8
ONMD▲ Buy$151
ONMD▲ Buy$16
ONMD▲ Buy$10
ONMD▲ Buy$9
ONMD▲ Buy$55
ONMD▲ Buy$3K
ONMD▲ Buy$41
ONMD▲ Buy$4K

We use analytics to understand how market-wall is used. No personal data is sold.